← Eichor
Condition: Polycystic Kidney Autosomal Dominant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Polycystic Kidney Autosomal Dominant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
Phase 2 · 43 location(s) · Vertex Pharmaceuticals Incorporated · NCT07161037Analysis of Patients With Autosomal Dominant Polycystic Kidney
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06759142Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
Phase 3 · 49 location(s) · The University of Queensland · NCT04939935Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
Phase 1 · 15 location(s) · AstraZeneca · NCT07228364Early PKD Observational Cohort Study
Phase N/A · 3 location(s) · University of Kansas Medical Center · NCT02936791Genetics in the Progression of Nephropathies
Phase N/A · 1 location(s) · Ospedale San Raffaele · NCT06416761Safety of RotigotiNe in Patients With Autosomal Dominant Polycystic Kidney Disease
Phase 2 · 4 location(s) · University Hospital, Rouen · NCT06291116ADPKD Patient Registry
Phase N/A · 1 location(s) · PKD Foundation · NCT04039061Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Phase N/A · 1 location(s) · Mayo Clinic · NCT04344769Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease
Phase N/A · 1 location(s) · King's College London · NCT07260071Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Phase 2 · 1 location(s) · Jemincare · NCT06800651HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life
Phase 3 · 12 location(s) · University Medical Center Groningen · NCT05373264Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases
NA · 1 location(s) · Mario Negri Institute for Pharmacological Research · NCT05996731Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study
Phase N/A · 4 location(s) · Children's Hospital of Philadelphia · NCT04338048Kidney Sodium Functional Imaging
Phase N/A · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT05014178Somatosensory Phenotyping of ADPKD
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06970028Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease
NA · 1 location(s) · Richard Fatica · NCT07454174RADIOLOGICAL AND CLINICAL EVALUATION OF RENAL EMBOLIZATION USING EVOH IN DIALYSIS PATIENTS WITH AUTOSOMAL DOMINANT POLYC
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07535385NOX4 and Related Biomarkers in ADPKD
Phase N/A · 1 location(s) · Mayo Clinic · NCT04630613National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852The German ADPKD Tolvaptan Treatment Registry
Phase N/A · 12 location(s) · University of Cologne · NCT02497521Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease
Phase 2 · 2 location(s) · Cantonal Hospital Graubuenden · NCT06435858Polycystic Kidney Disease Data Repository
Phase N/A · 1 location(s) · The Rogosin Institute · NCT00792155A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease
Phase 2 · 2 location(s) · University Medical Center Groningen · NCT05478083STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease
Phase 3 · 30 location(s) · University of Cologne · NCT07280585Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment
NA · 9 location(s) · Seoul National University Hospital · NCT06618638Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
Phase 1 · 12 location(s) · PYC Therapeutics · NCT06714006ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Po
Phase 2 · 75 location(s) · Calico Life Sciences LLC · NCT06902558A Prospective Observational Study of Foam Sclerotherapy .
Phase N/A · 1 location(s) · Mayo Clinic · NCT04111692Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
Phase 2 · 1 location(s) · University of Colorado, Denver · NCT06582875
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.